• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

针对海洛因依赖者的单次与重复疗程氯胺酮辅助心理治疗

Single versus repeated sessions of ketamine-assisted psychotherapy for people with heroin dependence.

作者信息

Krupitsky Evgeny M, Burakov Andrei M, Dunaevsky Igor V, Romanova Tatyana N, Slavina Tatyana Y, Grinenko Alexander Y

机构信息

Research Laboratory, St. Petersburg Regional Center of Addictions and Psychopharmacology, St. Petersburg State Pavlov Medical University, St. Petersburg, Russia.

出版信息

J Psychoactive Drugs. 2007 Mar;39(1):13-9. doi: 10.1080/02791072.2007.10399860.

DOI:10.1080/02791072.2007.10399860
PMID:17523581
Abstract

A prior study found that one ketamine-assisted psychotherapy session was significantly more effective than active placebo in promoting abstinence (Krupitsky et al. 2002). In this study of the efficacy of single versus repeated sessions of ketamine-assisted psychotherapy in promoting abstinence in people with heroin dependence, 59 detoxified inpatients with heroin dependence received a ketamine-assisted psychotherapy (KPT) session prior to their discharge from an addiction treatment hospital, and were then randomized into two treatment groups. Participants in the first group received two addiction counseling sessions followed by two KPT sessions, with sessions scheduled on a monthly interval (multiple KPT group). Participants in the second group received two addiction counseling sessions on a monthly interval, but no additional ketamine therapy sessions (single KPT group). At one-year follow-up, survival analysis demonstrated a significantly higher rate of abstinence in the multiple KPT group. Thirteen out of 26 subjects (50%) in the multiple KPT group remained abstinent, compared to 6 out of 27 subjects (22.2%) in the single KPT group (p < 0.05). No differences between groups were found in depression, anxiety, craving for heroin, or their understanding of the meaning of their lives. It was concluded that three sessions of ketamine-assisted psychotherapy are more effective than a single session for the treatment of heroin addiction.

摘要

先前的一项研究发现,在促进戒毒方面,一次氯胺酮辅助心理治疗疗程比活性安慰剂显著更有效(Krupitsky等人,2002年)。在这项关于单次与重复氯胺酮辅助心理治疗疗程对海洛因依赖者促进戒毒效果的研究中,59名已戒毒的海洛因依赖住院患者在从戒毒治疗医院出院前接受了一次氯胺酮辅助心理治疗(KPT)疗程,然后被随机分为两个治疗组。第一组参与者接受两次成瘾咨询疗程,随后是两次KPT疗程,疗程安排为每月一次(多次KPT组)。第二组参与者每月接受两次成瘾咨询疗程,但不再接受额外的氯胺酮治疗疗程(单次KPT组)。在一年的随访中,生存分析表明多次KPT组的戒毒率显著更高。多次KPT组的26名受试者中有13名(50%)保持戒毒状态,而单次KPT组的27名受试者中有6名(22.2%)保持戒毒状态(p<0.05)。在抑郁、焦虑、对海洛因的渴望或他们对生活意义的理解方面,两组之间未发现差异。研究得出结论,三次氯胺酮辅助心理治疗疗程在治疗海洛因成瘾方面比单次疗程更有效。

相似文献

1
Single versus repeated sessions of ketamine-assisted psychotherapy for people with heroin dependence.针对海洛因依赖者的单次与重复疗程氯胺酮辅助心理治疗
J Psychoactive Drugs. 2007 Mar;39(1):13-9. doi: 10.1080/02791072.2007.10399860.
2
Ketamine psychotherapy for heroin addiction: immediate effects and two-year follow-up.氯胺酮心理疗法治疗海洛因成瘾:即时效果及两年随访
J Subst Abuse Treat. 2002 Dec;23(4):273-83. doi: 10.1016/s0740-5472(02)00275-1.
3
Ketamine psychedelic therapy (KPT): a review of the results of ten years of research.氯胺酮迷幻疗法(KPT):十年研究结果综述
J Psychoactive Drugs. 1997 Apr-Jun;29(2):165-83. doi: 10.1080/02791072.1997.10400185.
4
Sustained incentive value of heroin-related cues in short- and long-term abstinent heroin users.短期和长期海洛因戒断者与海洛因相关线索的持续激励价值。
Eur Neuropsychopharmacol. 2013 Oct;23(10):1270-9. doi: 10.1016/j.euroneuro.2012.11.007. Epub 2012 Dec 7.
5
A proof-of-concept investigation into ketamine as a pharmacological treatment for alcohol dependence: study protocol for a randomised controlled trial.一项关于氯胺酮作为酒精依赖药物治疗的概念验证性研究:一项随机对照试验的研究方案
Trials. 2017 Apr 4;18(1):159. doi: 10.1186/s13063-017-1895-6.
6
[Alcohol dependence syndrome and before-discharge intervention method (BDIM)--Report 2. Statistical analysis of BDIM].[酒精依赖综合征与出院前干预方法(BDIM)——报告2. BDIM的统计分析]
Nihon Arukoru Yakubutsu Igakkai Zasshi. 2004 Feb;39(1):78-88.
7
Use of qigong therapy in the detoxification of heroin addicts.气功疗法在海洛因成瘾者戒毒中的应用。
Altern Ther Health Med. 2002 Jan-Feb;8(1):50-4, 56-9.
8
Ketamine Assisted Psychotherapy (KAP): Patient Demographics, Clinical Data and Outcomes in Three Large Practices Administering Ketamine with Psychotherapy.氯胺酮辅助心理治疗(KAP):在三家大型机构中,氯胺酮联合心理治疗的患者特征、临床数据和结局。
J Psychoactive Drugs. 2019 Apr-Jun;51(2):189-198. doi: 10.1080/02791072.2019.1587556. Epub 2019 Mar 27.
9
A randomized, controlled, pilot trial of methylphenidate and cognitive-behavioral group therapy for cocaine dependence in heroin prescription.一项随机对照的初步试验研究:哌醋甲酯与认知行为团体治疗对海洛因处方背景下可卡因依赖的疗效。
J Clin Psychopharmacol. 2013 Feb;33(1):104-8. doi: 10.1097/JCP.0b013e31827bfff4.
10
Naltrexone with or without fluoxetine for preventing relapse to heroin addiction in St. Petersburg, Russia.在俄罗斯圣彼得堡,纳曲酮联合或不联合氟西汀用于预防海洛因成瘾复发的研究
J Subst Abuse Treat. 2006 Dec;31(4):319-28. doi: 10.1016/j.jsat.2006.05.005. Epub 2006 Jul 24.

引用本文的文献

1
Ketamine-Assisted Recovery (KARE): protocol for an open-label pilot trial of ketamine-assisted psychotherapy for publicly insured patients with methamphetamine use disorder and HIV risks.氯胺酮辅助康复(KARE):一项针对有甲基苯丙胺使用障碍和感染艾滋病毒风险的公共保险患者的氯胺酮辅助心理治疗开放标签试点试验方案。
BMJ Open. 2025 Aug 24;15(8):e100775. doi: 10.1136/bmjopen-2025-100775.
2
Psychedelic-Assisted Therapy: Potential Benefits and Challenges in Mental Health Treatment.迷幻辅助疗法:心理健康治疗中的潜在益处与挑战
Med Sci Monit. 2025 Aug 9;31:e948302. doi: 10.12659/MSM.948302.
3
Novel potential pharmacological approaches in treating eating disorders comorbid with substance use disorders.
治疗与物质使用障碍共病的饮食失调的新型潜在药理学方法。
Biomed Pharmacother. 2025 Aug;189:118327. doi: 10.1016/j.biopha.2025.118327. Epub 2025 Jul 4.
4
Abuse liability for esketamine in a cohort of patients undergoing an acute treatment course to manage treatment-resistant depression: a secondary analysis of an observational study in real-world clinical practicee.在一组接受急性治疗疗程以管理难治性抑郁症的患者中艾氯胺酮的滥用可能性:一项真实世界临床实践中观察性研究的二次分析
Ther Adv Drug Saf. 2025 Jun 19;16:20420986251347360. doi: 10.1177/20420986251347360. eCollection 2025.
5
Ketamine in treating opioid use disorder and opioid withdrawal: a scoping review.氯胺酮治疗阿片类物质使用障碍和阿片类物质戒断:一项范围综述
Front Psychiatry. 2025 Apr 30;16:1552084. doi: 10.3389/fpsyt.2025.1552084. eCollection 2025.
6
The therapeutic effects of psychedelics for opioid use disorder: A systematic review of clinical studies.迷幻药治疗阿片类物质使用障碍的疗效:临床研究的系统评价
Psychiatry Res. 2025 Jun;348:116446. doi: 10.1016/j.psychres.2025.116446. Epub 2025 Mar 15.
7
Effects of psychedelics on opioid use disorder: a scoping review of preclinical studies.致幻剂对阿片类物质使用障碍的影响:临床前研究的范围综述
Cell Mol Life Sci. 2025 Jan 21;82(1):49. doi: 10.1007/s00018-024-05519-2.
8
Redefining Ketamine Pharmacology for Antidepressant Action: Synergistic NMDA and Opioid Receptor Interactions?重新定义氯胺酮抗抑郁作用的药理学:NMDA与阿片受体的协同相互作用?
Am J Psychiatry. 2025 Mar 1;182(3):247-258. doi: 10.1176/appi.ajp.20240378. Epub 2025 Jan 15.
9
Ketamine-Assisted Psychotherapy for Antisocial Personality Disorder: A Case Report.氯胺酮辅助心理治疗反社会人格障碍:一例报告
J Psychoactive Drugs. 2025 Jan 7:1-7. doi: 10.1080/02791072.2025.2449911.
10
Ketamine and Hydroxynorketamine as Novel Pharmacotherapies for the Treatment of Opioid Use Disorders.氯胺酮和羟基去甲氯胺酮作为治疗阿片类物质使用障碍的新型药物疗法。
Biol Psychiatry. 2025 Mar 15;97(6):563-579. doi: 10.1016/j.biopsych.2024.09.008. Epub 2024 Sep 16.